
LXEO
USDLexeo Therapeutics Inc. Common Stock
$8.190-0.110 (-1.325%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$8.300
最高
$8.355
最低
$7.660
交易量
2.85M
公司基本面
市值
597.8M
行業
生物科技
國家
United States
交易統計
平均交易量
1.04M
交易所
NGM
貨幣
USD
52週範圍
最低 $1.45當前 $8.190最高 $11.72
相關新聞
PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity InsiderNews Commentary – Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms,...
查看更多
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $13
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Lexeo Therapeutics with a Buy and lowers the price target from $15 to $13.
查看更多
Analyst Upgrades
Chardan Capital Maintains Buy on Lexeo Therapeutics, Raises Price Target to $17
Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics with a Buy and raises the price target from $15 to $17.
查看更多
GlobeNewswire
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval Interim clinical data
查看更多